SCHEMBL7681015

SCHEMBL7681015

COc1cccc(S(=O)(=O)NCCC(=O)N2CCc3ncn(C)c3C2c2ccc(C#N)c(F)c2)c1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
L3MBTL1 Q9Y468 1/20 0.39
ALDH1A1 P00352 1/20 0.37
MAPK1 P28482 1/20 0.37
TRPV4 Q9HBA0 3/20 0.37
KIF11 P52732 1/20 0.35
GFER P55789 1/20 0.35
DGAT1 O75907 1/20 0.35
MGAT3 Q09327 1/20 0.35
MGAT2 Q10469 1/20 0.35
MEP1B Q16820 1/20 0.35
SCN9A Q15858 1/20 0.34
NPC1 O15118 1/20 0.34
CYP1A2 P05177 1/20 0.34
CYP2D6 P10635 1/20 0.34
HPGD P15428 1/20 0.34
CYP2C19 P33261 1/20 0.34
RAB9A P51151 1/20 0.34
TPH1 P17752 3/20 0.34
MAPT P10636 1/20 0.34
AKR1C3 P42330 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7686665 0.91 KIF11 (0.39) ALDH1A1MAPK1TRPV4KIF11TPH1
SCHEMBL7754941 0.69 TRPV4 (0.39) L3MBTL1ALDH1A1TRPV4MEP1BCYP2D6
SCHEMBL7754946 0.69 L3MBTL1 (0.40) L3MBTL1TRPV4MEP1B
SCHEMBL7220418 0.69 ALDH1A1 (0.40) L3MBTL1ALDH1A1TRPV4MEP1B
SCHEMBL7220168 0.69 FNTA (0.37) L3MBTL1ALDH1A1TRPV4MEP1B
SCHEMBL7680485 0.66 GPR119 (0.43) ALDH1A1RAB9ATPH1MAPT
SCHEMBL7680493 0.65 GPR119 (0.42) ALDH1A1RAB9ATPH1MAPT
SCHEMBL3199069 0.62 ATM (0.64) L3MBTL1ALDH1A1MAPK1MEP1BMAPT
SCHEMBL7686709 0.62 CYP11B1 (0.36)
SCHEMBL20702465 0.61 AR (0.52) L3MBTL1ALDH1A1MEP1BMAPTPKM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6350755-B1 PEPTIDOMIMETIC COMPOUNDS THAT DO NOT HAVE A THIOL MOIETY; THERAPY OF ARTERIOSCLEROSIS AND DIABETIC VASCULAR PATHOLOGIES; MERCK & CO., INC. 2002-02-26 US disclosed